Data is not available at this time.
Everjoy Health Group operates as a diversified enterprise with core operations spanning ceramic tile manufacturing, healthcare services, and real estate investment. The company maintains a dual focus on industrial production through its established tile business while strategically expanding into China's growing medical and pension services sector. This hybrid model positions Everjoy at the intersection of traditional manufacturing and service-oriented healthcare, leveraging its industrial foundation to support ventures in elderly care and medical facilities. Within China's competitive construction materials market, the company faces pressure from both domestic manufacturers and evolving consumer preferences, while its healthcare segment operates in a rapidly expanding but regulated environment. The company's market position reflects this transitional phase, balancing its legacy industrial operations with strategic investments in healthcare properties and services that target demographic shifts toward an aging population. This diversification strategy aims to create synergies between its real estate holdings and service offerings, though execution across distinct sectors presents ongoing operational challenges.
The company generated revenue of approximately CNY 1.20 billion for the period but reported a net loss of CNY 147 million, indicating significant profitability challenges. Operating cash flow remained positive at CNY 82 million, suggesting some operational cash generation despite the bottom-line deficit. Capital expenditures of CNY 32 million were modest relative to revenue, reflecting constrained investment activity across its diversified business segments during this period of financial pressure.
Diluted earnings per share stood at -CNY 0.16, reflecting the company's current lack of earnings power amid its strategic transition. The negative profitability metrics indicate capital efficiency challenges as the company balances its traditional tile manufacturing operations with newer healthcare investments. The modest positive operating cash flow provides some buffer, but sustained losses question the current efficiency of deployed capital across its business portfolio.
Everjoy maintains a cash position of CNY 234 million against total debt of CNY 531 million, indicating a leveraged balance sheet structure. The debt-to-cash ratio suggests limited liquidity headroom, though the positive operating cash flow provides some financial flexibility. The company's financial health appears constrained by its debt load relative to its cash resources and current profitability challenges.
The company suspended dividend payments during this period, consistent with its loss-making position and focus on preserving capital. Current trends reflect a transitional phase as Everjoy navigates between its established tile business and newer healthcare ventures. The absence of shareholder returns underscores the priority given to operational stabilization and strategic repositioning amid challenging market conditions.
With a market capitalization of approximately CNY 4.10 billion, the market appears to be assigning some premium to the company's strategic repositioning into healthcare, despite current profitability challenges. The beta of 0.853 suggests moderate volatility relative to the broader market, reflecting investor perception of its hybrid business model's risk profile. Valuation metrics likely incorporate expectations for successful execution of its healthcare diversification strategy.
Everjoy's primary strategic advantage lies in its diversified approach targeting China's aging population through healthcare services, though execution risks remain substantial. The outlook depends on effectively managing the transition from traditional manufacturing to service-oriented healthcare while addressing current profitability issues. Success will require demonstrating tangible progress in integrating its real estate assets with medical and pension services to create sustainable value streams.
Company filingsMarket data
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |